Biopharmaceutics announces new board appointment.BELLPORT, N.Y.--(BUSINESS WIRE)--Oct. 21, 1996--Biopharmaceutics Inc., (OTCBB OTCBB See OTC Bulletin Board (OTCBB). : BOPH BOPH Board of Parole Hearings (Canada; also seen as BPH) ) announced today that it has appointed Jonathan Rosen to its board of directors. Rosen, who is president of Bluelake Capital Inc., is a London and Los Angeles Los Angeles (lôs ăn`jələs, lŏs, ăn`jəlēz'), city (1990 pop. 3,485,398), seat of Los Angeles co., S Calif.; inc. 1850. based investment banker Investment Banker A person representing a financial institution that is in the business of raising capital for corporations and municipalities. Notes: An investment banker may not accept deposits or make commercial loans. , whose firm located and arranged for Biopharmaceutics' March 1996 acquisition of Feminine Hygiene brands from London International U.S. Holdings Inc. As announced previously, Bluelake is continuing to look for other suitable acquisitions for Biopharmaceutics. Biopharmaceutics' president, Edward Fine, stated, "I am pleased to have Mr. Rosen on our board. His advice was crucial during our negotiations to acquire the Feminine Hygiene Product brands. We feel that his appointment to our board at this time will add strength to our corporate profile and bring enhanced focus to our search for acquisition candidates." CONTACT: Biopharmaceutics Inc., Bellport Stuart Fine, 516/286-5800 |
|
||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion